CD8A and neoplasm: As these states appear to be largely regulated at an epigenetic level, ATAC-seq has been used to reveal distinct chromatin states that distinguish dysfunctional tumor-specific CD8+ T cells that can be recovered from those that are resistant to reprogramming (Philip et al., 2017).